Microenvironment Remodeling Micelles for Alzheimer's Disease Therapy by Early Modulation of Activated Microglia

Citations Over TimeTop 10% of 2018 papers

Abstract

Current strategies for Alzheimer's disease (AD) treatments focus on pathologies in the late stage of the disease progression. Poor clinical outcomes are displayed due to the irreversible damages caused by early microglia abnormality which triggers disease development before identical symptoms emerge. Based on the crosstalk between microglia and brain microenvironment, a reactive oxygen species (ROS)-responsive polymeric micelle system (Ab-PEG-LysB/curcumin (APLB/CUR)) is reported to normalize the oxidative and inflammatory microenvironment and reeducate microglia from an early phase of AD. Through an β-amyloid (Aβ) transportation-mimicked pathway, the micelles can accumulate into the diseased regions and exert synergistic effects of polymer-based ROS scavenging and cargo-based Aβ inhibition upon microenvironment stimuli. This multitarget strategy exhibits gradual correction of the brain microenvironment, efficient neuroprotection, and microglia modulation, leading to decreased Aβ plaque burdens and consequently enhanced cognitive functions in APPswe/PSEN1dE9 model mice. The results indicate that microglia can be exploited as an early target for AD treatment and their states can be controlled via microenvironment modulation.

Related Papers

• → Efficient Strategies for Microglia Replacement in the Central Nervous System(2020)157 cited
• → Microglia derived from the axotomized adult rat facial nucleus uptake glutamate and metabolize it to glutamine in vitro(2016)6 cited
• → Microglial Kv1.3 Channels as a Potential Target for Alzheimer's Disease(2012)1 cited
• Contributions of Microglia in the Healthy and Injured Brain(2015)
• → Reverse Micelles, Enzymes(1999)